Abstract

http://ssrn.com/abstract=2043263
 


 



A Thousand Tiny Pieces: The Federal Circuit’s Fractured Myriad Ruling, Lessons to Be Learned, and the Way Forward


Jonathan R. K. Stroud


Finnegan, Henderson, Farabow, Garrett & Dunner LLP; American University Washington College of Law

September 20, 2011

IP Theory, Vol. 3, 2012
American University, WCL Research Paper

Abstract:     
The Supreme Court granted, vacated, and remanded the infamous Ass’n of Molecular Pathology v. U.S. Patent & Trademark Office (Myriad I), gene-isolation patentability case to the Court of Appeals for the Federal Circuit (CAFC) in light of the recent Prometheus decision, which held 9-0 that a certain diagnostic method was invalid subject matter because it was an abstract idea merely modified by other obvious steps. This Article argues that Myriad should be affirmed again by the Federal Circuit, particularly in light of Prometheus, in order to inject certainty, clarity, and consistency into the § 101 patentable subject matter jurisprudence.

Number of Pages in PDF File: 24

Keywords: Myriad, Genetics, Diagnostics, Patents, Subject-Matter, 101, Prometheus, GVR, FDA, Court of Appeals for the Federal Circuit, Federal Circuit, AMP v. USPTO

Accepted Paper Series





Download This Paper

Date posted: April 22, 2012  

Suggested Citation

Stroud, Jonathan R. K., A Thousand Tiny Pieces: The Federal Circuit’s Fractured Myriad Ruling, Lessons to Be Learned, and the Way Forward (September 20, 2011). IP Theory, Vol. 3, 2012; American University, WCL Research Paper. Available at SSRN: http://ssrn.com/abstract=2043263

Contact Information

Jonathan R. K. Stroud (Contact Author)
Finnegan, Henderson, Farabow, Garrett & Dunner LLP ( email )
901 New York Ave. NW
Washington, DC 20001
United States
American University Washington College of Law ( email )
4801 Massachusetts Avenue N.W.
Washington, DC 20016
United States
Feedback to SSRN


Paper statistics
Abstract Views: 715
Downloads: 52
Download Rank: 231,755

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo6 in 0.343 seconds